A 60-million Euro fine for AstraZeneca. A 10-million Euro fine for Bayer. Dawn raids at Pfizer, SanofiAventis and GlaxoSmithKline. Pharma and medical device companies have been targeted in a number of major antitrust investigations in Europe in recent years. It is absolutely vital that any company doing business in Europe be aware of existing antitrust provisions, and perhaps especially important for those in the life sciences. This presentation gives a general overview of EU antitrust law, and highlights those areas of particular relevance to medical device and pharmaceutical companies. The presentation places added emphasis on identifying special areas of risk, such as agreements restricting competition, information sharing between competitors, distribution agreements and abuse of market-dominating positions. Our speakers also discuss when you should seek legal assistance, and how to behave in the event of dawn raids.
Complying with EU Antitrust Laws was presented by Marc Besen & Dr. Christian Mayer, Partner & Associate, with Clifford Chance and aired on 2009-03-10. For more details or to download this event, please visit our site at www.fxconferences.com
